Our Approach
Pace Life Sciences Boston has the experienced staff and modern equipment to work on the development of any number of biologic drug products including proteins, peptides, monoclonal antibodies (mAbs), bispecific antibodies, antibody-drug conjugates (ADCs), and microbiome or other bacterially derived products.
We employ a rational and science-driven approach based on the physicochemical and biophysical behavior of a compound to develop an analytical strategy to rapidly assess relevant attributes. Based on the intended route of administration and indications, formulations are designed, characterized and evaluated for their intended performance.